Dataset
Oxomemazine; LC-ESI-Q; MS; POS; 45 V
Chemical Information
| InChI | InChI=1S/C18H22N2O2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)23(21,22)18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3 |
|---|---|
| SMILES | CN(C)CC(C)CN(c21)c(c3)c(ccc3)S(=O)(=O)c(cccc2)1 |
| InChI Key | QTQPVLDZQVPLGV-UHFFFAOYSA-N |
| Molecular Formula | C18H22N2O2S |
| Exact Mass | 330.140 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-nc/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA000490 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2016-01-19 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| 15421542 | PubChem: Thomson Pharma |
| CHEMBL2104734 | ChEMBL |
| PD014405 | ProbesDrugs |
| SCHEMBL423634 | SureChEMBL |
| 3689-50-7 | ACToR |
| HMDB0240230 | Human Metabolome Database |
| DB13820 | DrugBank |
| Q824SGH3RN | FDA SRS |
| 305MB38V1C | FDA SRS |
| 5GP9538P4S | FDA SRS |
| DTXSID5023405 | EPA CompTox Dashboard |
| 135408 | ChEBI |
| 2025 | DrugCentral |
| J8.210D | Nikkaji |
| CB1236273 | ChemicalBook |
| OXOMEMAZINE | clinicaltrials |
| HY-136587 | MedChemExpress |
| 19396 | PubChem |
| The data in this table is sourced from UniChem at EBI. | |